{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:13:08Z","timestamp":1793643188458,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":76,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.seizure.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T05:17:24Z","timestamp":1684646244000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients\u2019 data analysis"],"prefix":"10.1016","volume":"109","author":[{"given":"Clarissa","family":"Corniello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3575-2942","authenticated-orcid":false,"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibilla","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cipollone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Liviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Melchiorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Granzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Anzellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-2574","authenticated-orcid":false,"given":"Stefano L.","family":"Sensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.seizure.2023.05.017_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.seizure.2023.05.017_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1684\/epd.2011.0426","article-title":"Epilepsy in adult patients with Down syndrome: a clinical-video EEG study","volume":"13","author":"Vignoli","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2023.05.017_bib0003","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/WNP.0b013e318230da76","article-title":"Clinical and EEG features of seizures in adults with down syndrome","volume":"28","author":"Lefter","year":"2011","journal-title":"J Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.seizure.2023.05.017_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1684\/epd.2011.0426","article-title":"Epilepsy in adult patients with Down syndrome: a clinical-video EEG study","volume":"13","author":"Vignoli","year":"2011","journal-title":"Epileptic Disorders"},{"issue":"7","key":"10.1016\/j.seizure.2023.05.017_bib0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.seizure.2010.04.008","article-title":"Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome","volume":"19","author":"De Simone","year":"2010","journal-title":"Seizure"},{"issue":"Suppl 11","key":"10.1016\/j.seizure.2023.05.017_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.44.s11.5.x","article-title":"Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures","volume":"44","author":"Wheless","year":"2003","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2023.05.017_bib0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13760-019-01239-8","article-title":"Valproate-induced rest tremor and parkinsonism","volume":"121","author":"Baizabal-Carvallo","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.seizure.2023.05.017_bib0008","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.3390\/jcm10132776","article-title":"Epilepsy in down syndrome: a highly prevalent comorbidity","volume":"10","author":"Altuna","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.seizure.2023.05.017_bib0009","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s00415-014-7376-x","article-title":"Apulian study group on senile myoclonic epilepsy. Progressive myoclonus epilepsy in Down syndrome patients with dementia","volume":"261","author":"d'Orsi","year":"2014","journal-title":"J Neurol"},{"issue":"2-3","key":"10.1016\/j.seizure.2023.05.017_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eplepsyres.2007.09.002","article-title":"Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late onset epilepsy","volume":"77","author":"Crespel","year":"2007","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.seizure.2023.05.017_bib0011","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1590\/S0004-282X1995000500014","article-title":"Myoclonic epilepsy of late onset in trisomy 21","volume":"53","author":"Li","year":"1995","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.seizure.2023.05.017_bib0012","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/seiz.2000.0500","article-title":"Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)","volume":"10","author":"M\u00f6ller","year":"2001","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.seizure.2023.05.017_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/epd.2010.0306","article-title":"Improvement of myoclonic epilepsy in Down syndrome treated with levetiracetam","volume":"12","author":"Sangani","year":"2010","journal-title":"Epileptic Disord"},{"issue":"7","key":"10.1016\/j.seizure.2023.05.017_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.seizure.2010.04.008","article-title":"Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome","volume":"19","author":"De Simone","year":"2010","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2023.05.017_bib0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000508357","article-title":"The effectiveness of perampanel for myoclonic seizures in down syndrome with isodicentric chromosome 21","volume":"12","author":"Obara","year":"2020","journal-title":"Case Rep Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2023.05.017_bib0016","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10072-022-06452-7","article-title":"Efficacy and tolerability of perampanel in a patient with Late-Onset myoclonic epilepsy in Down syndrome (LOMEDS): a case report","volume":"44","author":"Corniello","year":"2023","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.seizure.2023.05.017_bib0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nrl.2014.12.008","article-title":"Myoclonic epilepsy in down syndrome and Alzheimer disease","volume":"32","author":"Aller-Alvarez","year":"2017","journal-title":"Neurologia"},{"issue":"5054","key":"10.1016\/j.seizure.2023.05.017_bib0018","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.seizure.2023.05.017_bib0019","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2016.12.014","article-title":"The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy","volume":"68","author":"Gholipour","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.05.017_bib0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-_\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.seizure.2023.05.017_bib0021","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/bies.201500004","article-title":"Neuronal hyperactivity\u2013a key defect in Alzheimer's disease?","volume":"37","author":"Busche","year":"2015","journal-title":"Bioessays"},{"key":"10.1016\/j.seizure.2023.05.017_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jnr.490380113","article-title":"Delayed application of aurintricarboxylic acid reduces glutamate-induced cortical neuronal injury","volume":"38","author":"Csernansky","year":"1994","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.seizure.2023.05.017_bib0023","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2023.05.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111434","article-title":"Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy","volume":"194","author":"Liguori","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.seizure.2023.05.017_bib0025","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer's disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2023.05.017_bib0026","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2023.05.017_bib0027","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S1474-4422(16)30193-4","article-title":"Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series","volume":"15","author":"Ryan","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2023.05.017_bib0028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer's disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.seizure.2023.05.017_bib0029","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archneurol.2011.104","article-title":"Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome","volume":"68","author":"Nelson","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2023.05.017_bib0030","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/cddis.2010.68","article-title":"Alterations of brain and cerebellar proteomes linked to A\u03b2 and tau pathology in a female triple-transgenic murine model of Alzheimer's disease","volume":"1","author":"Ciavardelli","year":"2010","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.seizure.2023.05.017_bib0031","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jalz.2014.10.007","article-title":"Down syndrome and Alzheimer's disease: Common pathways, common goals","volume":"11","author":"Hartley","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.seizure.2023.05.017_bib0032","series-title":"Imaging brain amyloid in non demented young adults with Down Syndrome","author":"Handen","year":"2013"},{"issue":"4","key":"10.1016\/j.seizure.2023.05.017_bib0033","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1212\/WNL.50.4.933","article-title":"Cortical myoclonus: sensorimotor hyperexcitability","volume":"50","author":"Mima","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2023.05.017_bib0034","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-210397","article-title":"Functional neurophysiological biomarkers of early-stage Alzheimer's disease: a perspective of network hyperexcitability in disease progression","volume":"88","author":"Tok","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.seizure.2023.05.017_bib0035","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.0000000000003048","article-title":"Seizures in dominantly inherited Alzheimer's disease","volume":"87","author":"Zarea","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.seizure.2023.05.017_bib0036","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.seizure.2023.05.017_bib0037","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13195-022-01064-x","article-title":"Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease","volume":"14","author":"Benejam","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"42","key":"10.1016\/j.seizure.2023.05.017_bib0038","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.seizure.2023.05.017_bib0039","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Alzheimer's Disease Cooperative Study. Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2023.05.017_bib0040","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.yebeh.2006.01.016","article-title":"Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate","volume":"8","author":"de Araujo Filho","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.05.017_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.630366","article-title":"Perampanel Improves Cortical Myoclonus and Disability in Progressive Myoclonic Epilepsies: A Case Series and a Systematic Review of the Literature","volume":"12","author":"Assenza","year":"2021","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2023.05.017_bib0042","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.clinph.2020.12.030","article-title":"Effects of the noncompetitive AMPA receptor antagonist perampanel on thalamo-cortical excitability: A study of high-frequency oscillations in somatosensory evoked potentials","volume":"132","author":"Lanzone","year":"2021","journal-title":"Clin Neurophysiol"},{"issue":"23","key":"10.1016\/j.seizure.2023.05.017_bib0043","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.3390\/ijms21239318","article-title":"Modulation of brain hyperexcitability: potential new therapeutic approaches in Alzheimer's disease","volume":"21","author":"Toniolo","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.seizure.2023.05.017_bib0044","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2021.12.038","article-title":"Effects of perampanel on cognitive behavior and GluR1 expression in immature mice of temporal lobe epilepsy","volume":"588","author":"Wang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.seizure.2023.05.017_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.seizure.2021.03.010","article-title":"SUDEP - more attention to the heart? A narrative review on molecular autopsy in epilepsy","volume":"87","author":"Fialho","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2023.05.017_bib46","doi-asserted-by":"crossref","unstructured":"Evangelista G, Dono F, Consoli S, Lanzone J, Corniello C, Russo M, Anzellotti F, Onofrj M, Vollono C, Sensi SL. Heart rate variability modification as a predictive factor of sudden unexpected death in epilepsy: How far are we? A systematic review and meta-analysis. Eur J Neurol. 2023, 18. doi:10.1111\/ene.15792.","DOI":"10.1111\/ene.15792"},{"key":"10.1016\/j.seizure.2023.05.017_bib47","doi-asserted-by":"crossref","unstructured":"Dono F, Evangelista G, Consoli S, Rodorigo D, Russo M, Carrarini C, Di Pietro M, De Angelis MV, Faustino M, Anzellotti F, Onofrj M, Di Iorio A, Sensi SL, Frazzini V, Vollono C. Perampanel enhances the cardiovagal tone and heart rate variability (HRV) in patients with drug-resistant temporal lobe epilepsy. Seizure. 2022, 99:16-23. doi: 10.1016\/j.seizure.","DOI":"10.1016\/j.seizure.2022.04.013"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:20:21Z","timestamp":1719800421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131123001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":47,"alternative-id":["S1059131123001474"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2023.05.017","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients\u2019 data analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}